NEW YORK (GenomeWeb) – Affymetrix reported today that it expects to report fourth quarter 2014 revenues of approximately $93 million, which would be a fraction of 1 percent higher than the $92.6 million in revenues reported for Q4 2013.

The revenue estimate is above Wall Street expectations for Q4 revenues of $89.9 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.